Recruiting
Phase 2

Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer

Sponsor:

University of British Columbia

Code:

NCT04812366

Conditions

Prostate Cancer

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Apalutamide 60mg Tab

Abiraterone Acetate 250mg

Prednisone 5mg Tab

Docetaxel

Niraparib 100mg Oral Capsule

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information